Literature DB >> 16778432

Methadone treatment in clinical practice in Italy: need for improvement.

Patrizia Schifano1, Anna Maria Bargagli, Valeria Belleudi, Laura Amato, Marina Davoli, Roberto Diecidue, Elisabetta Versino, Federica Vigna-Taglianti, Fabrizio Faggiano, Carlo A Perucci.   

Abstract

BACKGROUND: Methadone at appropriate doses has been demonstrated to be the most effective means for retaining patients in treatment and suppressing heroin use. AIM: To describe the modalities of day-to-day provision of methadone maintenance treatments (MMT) in Italian public health centres and to analyze the duration of MMTs by dose and by association with psychosocial treatments. PATIENTS AND METHODS: We analyzed 8,378 subjects, 18 years of age or over, enrolled between September 1998 and March 2001 in one of 115 public treatment centres for heroin dependence in Italy. Treatment data were collected for each subject from enrolment to the end of the study period (maximum of 18 months).
RESULTS: Of the total of 29,495 treatments delivered, 21.0% were methadone maintenance, and 34.4% were methadone detoxification. Fifty percent of MMTs offered had a mean dose less than or equal to 40 mg/day, and only 19% had doses higher than or equal to 60 mg/day; treatments with doses higher than 60 mg/day lasted longer than treatments with lower doses. Differences in treatment length were observed between MMTs associated with a psychosocial treatment and those offered alone, only for doses <60 mg/day.
CONCLUSIONS: In Italy, MMTs are delivered at inappropriate doses in more than 80% of the cases. The increase of methadone doses to adequate levels as indicated by the literature is necessary to ensure proper and effective use of MMTs in public treatment centres for heroin users.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778432     DOI: 10.1159/000092113

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  3 in total

1.  Treating chronic hepatitis C in recovering opiate addicts: yes, we can.

Authors:  M J Kreek; A H Talal; P Piccolo
Journal:  Dig Liver Dis       Date:  2009-02-23       Impact factor: 4.088

2.  The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment.

Authors:  Jacopo V Bizzarri; Valentina Casetti; Livia Sanna; Angelo Giovanni Icro Maremmani; Luca Rovai; Silvia Bacciardi; Daria Piacentino; Andreas Conca; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2016-11-25       Impact factor: 3.455

3.  The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance.

Authors:  Angelo G I Maremmani; Alessandro Pallucchini; Luca Rovai; Silvia Bacciardi; Vincenza Spera; Marco Maiello; Giulio Perugi; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2018-04-18       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.